SecBot SecBot
SECBOTREPLAY Home › Report › GSK

GSK · GSK filed a Form 6-K disclosing routine dividend reinvestment…

GSK plc · 6-K filed Aug 18, 2026 at 10:34 ET

At the news

NEUTRALIMPACT 1/10

6-K filed Aug 18, 2026 at 10:34 ET

GSK filed a Form 6-K disclosing routine dividend reinvestment transactions by three PDMRs (Dr. Hal Barron, James Ford, and Maya Martinez-Davis) in their Executive Supplemental Savings Plan and 401(k) accounts. These are notional, plan-level acquisitions totaling approximately 2,489 ADSs at $49.52 each, entirely mechanical and administrative in nature, with no discretionary insider signal.

  • Dr. Hal Barron (Non-Executive Director) acquired 2,279.563 notional ADS at $49.52 via supplemental plan dividend reinvestment.
  • James Ford (SVP & Group General Counsel) acquired 53.89 notional ADS at $49.52 via supplemental plan dividend reinvestment.
  • Maya Martinez-Davis (President, US) acquired 82.133 notional ADS at $49.52 via supplemental plan dividend reinvestment.
  • Dr. Hal Barron also acquired 73 ADS at $49.52 via 401(k) dividend reinvestment.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access